Methods For Increasing The Capacity Of Purification Processes

US2019153027A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019153027-A1
Application numberUS-201916259489-A
CountryUS
Kind codeA1
Filing dateJan 28, 2019
Priority dateJun 16, 2014
Publication dateMay 23, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In various embodiments, the present invention provides a process for separating target proteins from non-target proteins in a sample comprising increasing the concentration of the target proteins and non-target proteins in the sample and subsequently delivering the concentrated sample to a chromatography device. In other embodiments, the invention relates to a process for increasing the capacity of a chromatography device for a target protein by delivering a concentrated sample comprising the target protein to a chromatography device.

First claim

Opening claim text (preview).

What is claimed is: 1 . A process for purifying target proteins from non-target proteins and viruses in a liquid sample, comprising: a) increasing a concentration of target proteins, non-target proteins, and viruses in the sample by a single-pass tangential flow filtration (SPTFF) process to produce a concentrated feed; b) delivering the concentrated feed to an anion exchange (AEX) chromatography device; c) separating the target proteins from the non-target proteins and viruses in the AEX chromatography device; and d) recovering the target proteins from the AEX chromatography device. 2 . The process of claim 1 , further comprising diafiltering the liquid sample prior to increasing the concentration of target proteins and non-target proteins in the sample by the SPTFF process. 3 . The process of claim 2 , wherein diafiltering the liquid sample includes adding a diafiltration solution to the unfiltered sample at a same rate of removing permeate from the sample during the SPTFF process. 4 . The process of claim 1 , wherein the SPTFF process provides direct flow-through concentration of the liquid sample to the AEX device. 5 . The process of claim 1 , wherein the AEX chromatography device includes an Eshmuno® Q resin. 6 . The process of claim 1 , wherein the SPTFF process is an ultrafiltration SPTFF process. 7 . The process of claim 1 , wherein the target proteins are monoclonal antibodies. 8 . The process of claim 1 , wherein the non-target proteins are host cell proteins from hybridoma cells expressing the target protein. 9 . A process for purifying target proteins from non-target proteins in a liquid sample, comprising: a) increasing a concentration of target proteins and non-target proteins in the sample by a single-pass tangential flow filtration (SPTFF) process to produce a concentrated feed; b) delivering the concentrated feed to protein A chromatography device; c) separating the target proteins from the non-target proteins in the protein A chromatography device; and d) recovering the target proteins from the protein A chromatography device. 10 . The process of claim 9 , wherein the SPTFF process provides direct flow-through concentration of the liquid sample to the protein A chromatography device. 11 . The process of claim 9 , wherein the protein A chromatography device includes a protein A affinity resin. 12 . The process of claim 9 , wherein the protein A chromatography device includes a protein A affinity membrane. 13 . The process of claim 9 , wherein the target proteins are monoclonal antibodies. 14 . The process of claim 9 , wherein the non-target proteins are host cell proteins from hybridoma cells expressing the target protein.

Assignees

Inventors

Classifications

  • Living organisms or biological materials · CPC title

  • Filtration · CPC title

  • Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

  • by filtration, ultrafiltration or reverse osmosis · CPC title

  • Parts of membrane modules specifically adapted for single use · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019153027A1 cover?
In various embodiments, the present invention provides a process for separating target proteins from non-target proteins in a sample comprising increasing the concentration of the target proteins and non-target proteins in the sample and subsequently delivering the concentrated sample to a chromatography device. In other embodiments, the invention relates to a process for increasing the capacit…
Who is the assignee on this patent?
Emd Millipore Corp
What technology area does this patent fall under?
Primary CPC classification B01D15/12. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Thu May 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).